MOREPENLAB.NS Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (15 May 2024 @ 06:00):

Morepen Laboratories Limited develops, manufactures, markets, and sells active pharmaceutical ingredients (APIs), branded and generic formulations, and home health products in India...

Stats
Today's Volume	2.26M
Average Volume	4.02M
Market Cap	23.87B
EPS	INR0 ( 2024-05-14 )
Next earnings date	( INR0 ) 2024-08-03
Last Dividend	INR0.600 ( 2002-09-18 )
Next Dividend	INR0 ( N/A )
P/E	31.13
ATR14	INR0.0680 (0.15%)

Volume Correlation

Long: 0.08 (neutral)

Short: -0.49 (neutral)

Signal:(44.064) Neutral

Morepen Laboratories Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Morepen Laboratories Correlation - Currency/Commodity

0.65
( moderate )

0.05
( neutral )

0.00
( neutral )

0.52
( weak )

0.23
( neutral )

0.07
( neutral )

Morepen Laboratories Financials

Annual	2022
Revenue:	INR14.18B
Gross Profit:	INR4.62B (32.58 %)
EPS:	INR0.770

FY	2022
Revenue:	INR14.18B
Gross Profit:	INR4.62B (32.58 %)
EPS:	INR0.770

FY	2022
Revenue:	INR15.42B
Gross Profit:	INR4.81B (31.18 %)
EPS:	INR2.26

FY	2021
Revenue:	INR11.75B
Gross Profit:	INR3.89B (33.06 %)
EPS:	INR2.16

Financial Reports:

No articles found.

Morepen Laboratories Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Morepen Laboratories Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 2.95 - low (50.00%) | Divividend Growth Potential Score: 2.82 - No dividend growth expected in the near future

Information

First Dividend	INR0.600	2000-04-28
Last Dividend	INR0.600	2002-09-18
Next Dividend	INR0	N/A
Payout Date	2002-10-08
Next Payout Date	N/A
# dividends	5	--
Total Paid Out	INR2.00	--
Avg. Dividend % Per Year	0.00%	--
Score	1.42	--
Div. Sustainability Score	2.95
Div.Growth Potential Score	2.82
Div. Directional Score	2.88	--

Next Divdend (Est)
(2024-07-15)

INR0 Estimate 0.00 %

Dividend Stability

0.01 Very Bad

Dividend Score

1.42

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2000	INR0	0.00%
2001	INR0	0.00%
2002	INR0	0.00%
2003	INR0	0.00%
2004	INR0	0.00%
2005	INR0	0.00%
2006	INR0	0.00%
2007	INR0	0.00%
2008	INR0	0.00%
2009	INR0	0.00%
2010	INR0	0.00%
2011	INR0	0.00%
2012	INR0	0.00%
2013	INR0	0.00%
2014	INR0	0.00%
2015	INR0	0.00%
2016	INR0	0.00%
2017	INR0	0.00%
2018	INR0	0.00%
2019	INR0	0.00%
2020	INR0	0.00%
2021	INR0	0.00%
2022	INR0	0.00%
2023	INR0	0.00%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
RPGLIFE.NS	Dividend Knight	2023-07-21	Annually	17	1.03%
LGBBROSLTD.NS	Dividend Knight	2023-09-15	Annually	17	1.61%
FOSECOIND.NS	Dividend Junior	2023-05-17	Annually	22	0.68%
APLLTD.NS	Dividend Knight	2023-07-28	Annually	13	0.84%
TECHNOE.NS	Dividend Junior	2023-09-15	Annually	16	1.13%
OLECTRA.NS	Dividend Junior	2023-09-21	Sporadic	23	0.03%
INFY.NS	Dividend King	2023-06-02	Semi-Annually	29	1.47%
CONCOR.NS	Dividend Knight	2023-09-18	Semi-Annually	23	0.89%
SHANKARA.NS	Dividend Junior	2023-06-14	Sporadic	8	0.18%
MANAKSIA.NS	Ex Dividend Knight	2023-09-14	Annually	17	2.93%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0467	1.500	9.07	10.00	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.0988	1.500	-0.0137	-0.0206	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	31.04	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	1.206	2.00	9.60	10.00	[0 - 30]
freeCashFlowPerShareTTM	1.206	2.00	9.40	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.359	1.000	7.36	7.36	[0.2 - 0.8]
operatingProfitMarginTTM	0.0661	1.000	-0.678	-0.678	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				2.95

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	31.70	1.000	6.90	0	[1 - 100]
returnOnEquityTTM	0.0988	2.50	-0.00883	-0.0206	[0.1 - 1.5]
freeCashFlowPerShareTTM	1.206	2.00	9.60	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	1.206	2.00	9.60	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	1.710	1.500	1.931	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0378	1.000	-1.555	0	[0.1 - 0.5]
Total Score				2.82

Morepen Laboratories Options Data

Calls

JSON decode error: Syntax error

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Morepen Laboratories

Morepen Laboratories Limited develops, manufactures, markets, and sells active pharmaceutical ingredients (APIs), branded and generic formulations, and home health products in India. The company offers APIs for anti-histaminic, anti-asthmatic, anti-hypercholesterolemic, anti-hypertensive, and anti-diabetic drugs; point of care and medical devices; and home diagnostic products, such as air purifiers, thermometers, stethoscopes, blood pressure monitors, pulse-oximeters, nebulizers, glucometers, strips, sanitizers, disinfectant solutions, masks and gloves, and others. It also provides Burnol, a burn cream; Lemolate for cough and cold; and Fiber-X, a sat isabgol; and formulations for gastro, antibiotics, vitamins, nutritional, and anti-diabetics, as well as cardiac. In addition, the company is involved in the product contract manufacturing and brand sharing businesses; and provision of over-the-counter products under the Dr. Morepen brand. It exports its products to approximately 75 countries. Morepen Laboratories Limited was incorporated in 1984 and is based in New Delhi, India.